- Biology & Life Sciences
Number of employees:
- Worldwide: 1300
- The Netherlands: 500
Location in The Netherlands:
Operates in the following countries:
Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer. For more than 20 years, Genmab’s vision to transform cancer treatment has driven its passionate, innovative and collaborative teams to invent next-generation antibody technology platforms and leverage translational research and data sciences, fueling multiple differentiated cancer treatments that make an impact on people’s lives. To develop and deliver novel therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. Genmab’s proprietary pipeline includes bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates.
Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com and follow us on Twitter.com/Genmab.
We are leaders in antibody biology and innovation who are committed to improving the lives of patients with cancer. We are deeply knowledgeable about antibody biology, and our teams use this expertise to create and develop differentiated antibody therapeutics. We are team players who solve problems. We are transforming the future of cancer therapeutics and are looking for bright minds to achieve this mission. We are growing and looking for teammates with integrity who are innovative, determined and collaborative.
If that sounds like you, join us and be a part of our mission to transform the future of cancer treatment.
We are looking for different types of participants who are eager to join Genmab: bachelor/master students, graduates, PHD graduates, English speaking participant, Dutch speakers, Participants who are looking for a first job or an internship.